chr2-161204747-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001199135.3(TANK):c.281C>A(p.Pro94Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000859 in 1,606,160 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001199135.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TANK | NM_001199135.3 | c.281C>A | p.Pro94Gln | missense_variant | 4/8 | ENST00000392749.7 | NP_001186064.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TANK | ENST00000392749.7 | c.281C>A | p.Pro94Gln | missense_variant | 4/8 | 1 | NM_001199135.3 | ENSP00000376505 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 25AN: 242046Hom.: 0 AF XY: 0.0000917 AC XY: 12AN XY: 130914
GnomAD4 exome AF: 0.0000915 AC: 133AN: 1454064Hom.: 0 Cov.: 31 AF XY: 0.0000830 AC XY: 60AN XY: 723172
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 05, 2024 | The c.281C>A (p.P94Q) alteration is located in exon 4 (coding exon 3) of the TANK gene. This alteration results from a C to A substitution at nucleotide position 281, causing the proline (P) at amino acid position 94 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at